Definium Therapeutics Inc (DFTX) PT Raised to $40 at Oppenheimer
Oppenheimer raised its price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
